TextAE configuration unavailable!

PubMed:20197700 JSONTXT

Annnotations TAB JSON ListView MergeView

    DisGeNET

    {"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":18,"end":21},"obj":"gene:2896"},{"id":"T1","span":{"begin":51,"end":72},"obj":"disease:C1504404"},{"id":"T2","span":{"begin":302,"end":308},"obj":"gene:23435"},{"id":"T3","span":{"begin":424,"end":429},"obj":"disease:C1504404"},{"id":"T4","span":{"begin":302,"end":308},"obj":"gene:23435"},{"id":"T5","span":{"begin":408,"end":410},"obj":"disease:C0002395"},{"id":"T6","span":{"begin":302,"end":308},"obj":"gene:23435"},{"id":"T7","span":{"begin":389,"end":406},"obj":"disease:C0002395"},{"id":"T8","span":{"begin":807,"end":810},"obj":"gene:2837"},{"id":"T9","span":{"begin":893,"end":898},"obj":"disease:C1504404"},{"id":"T10","span":{"begin":822,"end":825},"obj":"gene:2896"},{"id":"T11","span":{"begin":873,"end":875},"obj":"disease:C0002395"},{"id":"T12","span":{"begin":822,"end":825},"obj":"gene:2896"},{"id":"T13","span":{"begin":893,"end":898},"obj":"disease:C1504404"},{"id":"T14","span":{"begin":846,"end":852},"obj":"gene:23435"},{"id":"T15","span":{"begin":873,"end":875},"obj":"disease:C0002395"},{"id":"T16","span":{"begin":807,"end":810},"obj":"gene:8170"},{"id":"T17","span":{"begin":893,"end":898},"obj":"disease:C1504404"},{"id":"T18","span":{"begin":807,"end":810},"obj":"gene:8170"},{"id":"T19","span":{"begin":873,"end":875},"obj":"disease:C0002395"},{"id":"T20","span":{"begin":807,"end":810},"obj":"gene:2837"},{"id":"T21","span":{"begin":873,"end":875},"obj":"disease:C0002395"},{"id":"T22","span":{"begin":846,"end":852},"obj":"gene:23435"},{"id":"T23","span":{"begin":893,"end":898},"obj":"disease:C1504404"},{"id":"T24","span":{"begin":1170,"end":1176},"obj":"gene:23435"},{"id":"T25","span":{"begin":1346,"end":1351},"obj":"disease:C1504404"},{"id":"T26","span":{"begin":1170,"end":1176},"obj":"gene:23435"},{"id":"T27","span":{"begin":1335,"end":1337},"obj":"disease:C0002395"},{"id":"T28","span":{"begin":1170,"end":1176},"obj":"gene:23435"},{"id":"T29","span":{"begin":1289,"end":1294},"obj":"disease:C1504404"},{"id":"T30","span":{"begin":1170,"end":1176},"obj":"gene:23435"},{"id":"T31","span":{"begin":1281,"end":1283},"obj":"disease:C0002395"},{"id":"T32","span":{"begin":1170,"end":1176},"obj":"gene:23435"},{"id":"T33","span":{"begin":1245,"end":1250},"obj":"disease:C1504404"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"},{"id":"R3","pred":"associated_with","subj":"T4","obj":"T5"},{"id":"R4","pred":"associated_with","subj":"T6","obj":"T7"},{"id":"R5","pred":"associated_with","subj":"T8","obj":"T9"},{"id":"R6","pred":"associated_with","subj":"T10","obj":"T11"},{"id":"R7","pred":"associated_with","subj":"T12","obj":"T13"},{"id":"R8","pred":"associated_with","subj":"T14","obj":"T15"},{"id":"R9","pred":"associated_with","subj":"T16","obj":"T17"},{"id":"R10","pred":"associated_with","subj":"T18","obj":"T19"},{"id":"R11","pred":"associated_with","subj":"T20","obj":"T21"},{"id":"R12","pred":"associated_with","subj":"T22","obj":"T23"},{"id":"R13","pred":"associated_with","subj":"T24","obj":"T25"},{"id":"R14","pred":"associated_with","subj":"T26","obj":"T27"},{"id":"R15","pred":"associated_with","subj":"T28","obj":"T29"},{"id":"R16","pred":"associated_with","subj":"T30","obj":"T31"},{"id":"R17","pred":"associated_with","subj":"T32","obj":"T33"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.\nBACKGROUND: Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in \u003e70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in \u003e20% of Alzheimer disease (AD) and \u003e70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C\u003eT) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls.\nOBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl.\nMETHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods.\nRESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele.\nCONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain."}

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":166,"end":174},"obj":"HP_0000726"},{"id":"T2","span":{"begin":389,"end":406},"obj":"HP_0002511"}],"text":"Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.\nBACKGROUND: Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in \u003e70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in \u003e20% of Alzheimer disease (AD) and \u003e70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C\u003eT) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls.\nOBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl.\nMETHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods.\nRESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele.\nCONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain."}

    Allie

    {"project":"Allie","denotations":[{"id":"SS1_20197700_2_0","span":{"begin":101,"end":122},"obj":"expanded"},{"id":"SS2_20197700_2_0","span":{"begin":124,"end":129},"obj":"abbr"},{"id":"SS1_20197700_3_0","span":{"begin":263,"end":334},"obj":"expanded"},{"id":"SS2_20197700_3_0","span":{"begin":336,"end":344},"obj":"abbr"},{"id":"SS1_20197700_4_0","span":{"begin":389,"end":406},"obj":"expanded"},{"id":"SS2_20197700_4_0","span":{"begin":408,"end":410},"obj":"abbr"},{"id":"SS1_20197700_6_0","span":{"begin":556,"end":578},"obj":"expanded"},{"id":"SS2_20197700_6_0","span":{"begin":580,"end":585},"obj":"abbr"}],"relations":[{"id":"AE1_20197700_2_0","pred":"abbreviatedTo","subj":"SS1_20197700_2_0","obj":"SS2_20197700_2_0"},{"id":"AE1_20197700_3_0","pred":"abbreviatedTo","subj":"SS1_20197700_3_0","obj":"SS2_20197700_3_0"},{"id":"AE1_20197700_4_0","pred":"abbreviatedTo","subj":"SS1_20197700_4_0","obj":"SS2_20197700_4_0"},{"id":"AE1_20197700_6_0","pred":"abbreviatedTo","subj":"SS1_20197700_6_0","obj":"SS2_20197700_6_0"}],"text":"Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.\nBACKGROUND: Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in \u003e70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in \u003e20% of Alzheimer disease (AD) and \u003e70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C\u003eT) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls.\nOBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl.\nMETHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods.\nRESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele.\nCONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain."}

    DisGeNET5_variant_disease

    {"project":"DisGeNET5_variant_disease","denotations":[{"id":"20197700-7#176#182#geners5848","span":{"begin":1085,"end":1091},"obj":"geners5848"},{"id":"20197700-7#60#65#diseaseC1504404","span":{"begin":969,"end":974},"obj":"diseaseC1504404"}],"relations":[{"id":"176#182#geners584860#65#diseaseC1504404","pred":"associated_with","subj":"20197700-7#176#182#geners5848","obj":"20197700-7#60#65#diseaseC1504404"}],"text":"Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.\nBACKGROUND: Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in \u003e70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in \u003e20% of Alzheimer disease (AD) and \u003e70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C\u003eT) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls.\nOBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl.\nMETHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods.\nRESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele.\nCONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain."}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"20197700-0#18#21#gene2896","span":{"begin":18,"end":21},"obj":"gene2896"},{"id":"20197700-0#51#72#diseaseC1504404","span":{"begin":51,"end":72},"obj":"diseaseC1504404"},{"id":"20197700-9#46#49#gene2896","span":{"begin":1431,"end":1434},"obj":"gene2896"},{"id":"20197700-9#81#92#gene2896","span":{"begin":1466,"end":1477},"obj":"gene2896"},{"id":"20197700-9#149#155#gene23435","span":{"begin":1534,"end":1540},"obj":"gene23435"},{"id":"20197700-9#176#178#diseaseC0002395","span":{"begin":1561,"end":1563},"obj":"diseaseC0002395"},{"id":"20197700-9#127#129#diseaseC0002395","span":{"begin":1512,"end":1514},"obj":"diseaseC0002395"},{"id":"20197700-9#176#178#diseaseC0002395","span":{"begin":1561,"end":1563},"obj":"diseaseC0002395"},{"id":"20197700-9#118#123#diseaseC1504404","span":{"begin":1503,"end":1508},"obj":"diseaseC1504404"},{"id":"20197700-9#176#178#diseaseC0002395","span":{"begin":1561,"end":1563},"obj":"diseaseC0002395"}],"relations":[{"id":"18#21#gene289651#72#diseaseC1504404","pred":"associated_with","subj":"20197700-0#18#21#gene2896","obj":"20197700-0#51#72#diseaseC1504404"},{"id":"46#49#gene2896176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#46#49#gene2896","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"46#49#gene2896127#129#diseaseC0002395","pred":"associated_with","subj":"20197700-9#46#49#gene2896","obj":"20197700-9#127#129#diseaseC0002395"},{"id":"46#49#gene2896176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#46#49#gene2896","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"46#49#gene2896118#123#diseaseC1504404","pred":"associated_with","subj":"20197700-9#46#49#gene2896","obj":"20197700-9#118#123#diseaseC1504404"},{"id":"46#49#gene2896176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#46#49#gene2896","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"81#92#gene2896176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#81#92#gene2896","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"81#92#gene2896127#129#diseaseC0002395","pred":"associated_with","subj":"20197700-9#81#92#gene2896","obj":"20197700-9#127#129#diseaseC0002395"},{"id":"81#92#gene2896176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#81#92#gene2896","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"81#92#gene2896118#123#diseaseC1504404","pred":"associated_with","subj":"20197700-9#81#92#gene2896","obj":"20197700-9#118#123#diseaseC1504404"},{"id":"81#92#gene2896176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#81#92#gene2896","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"149#155#gene23435176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#149#155#gene23435","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"149#155#gene23435127#129#diseaseC0002395","pred":"associated_with","subj":"20197700-9#149#155#gene23435","obj":"20197700-9#127#129#diseaseC0002395"},{"id":"149#155#gene23435176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#149#155#gene23435","obj":"20197700-9#176#178#diseaseC0002395"},{"id":"149#155#gene23435118#123#diseaseC1504404","pred":"associated_with","subj":"20197700-9#149#155#gene23435","obj":"20197700-9#118#123#diseaseC1504404"},{"id":"149#155#gene23435176#178#diseaseC0002395","pred":"associated_with","subj":"20197700-9#149#155#gene23435","obj":"20197700-9#176#178#diseaseC0002395"}],"text":"Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly.\nBACKGROUND: Hippocampal sclerosis (HpScl) is common in elderly subjects with dementia, either alone or accompanied by other pathologic processes. It is also found in \u003e70% of frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). TDP-43 inclusions are detected in \u003e20% of Alzheimer disease (AD) and \u003e70% of HpScl cases. The most common cause of FTLD-TDP is mutation in the progranulin gene (GRN). Recently, a common genetic variant in the 3' untranslated region (3'UTR) of GRN (rs5848; c.*78C\u003eT) located in a microRNA binding site regulated progranulin expression, and the T-allele was increased in FTLD-TDP compared to controls.\nOBJECTIVE: The goal of this study was to determine if the 3'UTR variant in GRN was associated with TDP-43 immunoreactivity in AD with and without HpScl.\nMETHODS: 644 cases of pathologically confirmed AD, including 57 with HpScl, were screened for TDP-43 immunoreactivity and were genotyped at the GRN 3'UTR single-nucleotide polymorphism rs5848 using previously published methods.\nRESULTS: There was a trend (p = 0.06) for TDP-43 immunoreactivity, but a very significant (p = 0.005) association of HpScl with the variant, with 72% of AD with HpScl carrying a T-allele, compared to 51% of AD without HpScl carrying a T-allele.\nCONCLUSION: The results suggest that a genetic variant in GRN leading to decreased levels of progranulin may be a risk factor for HpScl in AD, while its role in TDP-43 immunoreactivity in AD remains less certain."}